Insider Transactions in Q2 2025 at Renovo Rx, Inc. (RNXT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 15
2025
|
Ramtin Agah Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+1.33%
|
$0
$0.9 P/Share
|
|
Apr 15
2025
|
Shaun Bagai Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
7,500
+2.29%
|
$0
$0.91 P/Share
|
|
Apr 11
2025
|
Ramtin Agah Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+1.79%
|
$0
$0.8 P/Share
|
|
Apr 10
2025
|
Ron Kocak VP, Controller and PAO |
BUY
Open market or private purchase
|
Direct |
6,500
+34.04%
|
$0
$0.79 P/Share
|
|
Apr 09
2025
|
Ron Kocak VP, Controller and PAO |
BUY
Open market or private purchase
|
Direct |
6,000
+49.61%
|
$0
$0.8 P/Share
|
|
Apr 09
2025
|
Ramtin Agah Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+2.71%
|
$0
$0.81 P/Share
|
|
Apr 09
2025
|
Shaun Bagai Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+3.1%
|
$0
$0.83 P/Share
|
|
Apr 08
2025
|
Ron Kocak VP, Controller and PAO |
BUY
Open market or private purchase
|
Direct |
95
+50.0%
|
$0
$0.8 P/Share
|
|
Apr 08
2025
|
Laurence Marton Director |
BUY
Open market or private purchase
|
Direct |
12,050
+20.87%
|
$0
$0.85 P/Share
|
|
Apr 08
2025
|
Ramtin Agah Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
26,000
+2.42%
|
$0
$0.84 P/Share
|
|
Apr 07
2025
|
Shaun Bagai Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+3.2%
|
$0
$0.83 P/Share
|